Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110479569 | 11047956 | 9 | F | 20140424 | 20160921 | 20150420 | 20160926 | EXP | US-PFIZER INC-2015130231 | PFIZER | 81.00 | YR | F | Y | 60.77000 | KG | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110479569 | 11047956 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | 21446 | 150 | MG | CAPSULE, HARD | TID | ||||||
| 110479569 | 11047956 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | RX14152527 | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
| 110479569 | 11047956 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | L75538 | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
| 110479569 | 11047956 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG | 21446 | 150 | MG | CAPSULE, HARD | |||||||
| 110479569 | 11047956 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 450 MG, 1X/DAY (150MG, THREE CAPSULES AT NIGHT) | 21446 | 450 | MG | CAPSULE, HARD | QD | ||||||
| 110479569 | 11047956 | 6 | SS | LYRICA | PREGABALIN | 1 | 300 MG, 1X/DAY (TWO 150MG TABLETS ONCE A DAY AT NIGHT) | 21446 | 300 | MG | CAPSULE, HARD | QD | |||||||
| 110479569 | 11047956 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 8 | C | LIOTHYRONINE | LIOTHYRONINE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 9 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 10 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 11 | C | VITAMIN B2 | RIBOFLAVIN | 1 | UNK [AFTER MEALS] | 0 | |||||||||||
| 110479569 | 11047956 | 12 | C | FLORASTOR | SACCHAROMYCES CEREVISIAE | 1 | 250 MG, UNK | 0 | 250 | MG | |||||||||
| 110479569 | 11047956 | 13 | C | MAGNESIUM | MAGNESIUM | 1 | UNK (400) | 0 | |||||||||||
| 110479569 | 11047956 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 15 | C | DULOXETINE. | DULOXETINE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 16 | C | ALPHA LIPOIC | 2 | UNK | 0 | ||||||||||||
| 110479569 | 11047956 | 17 | C | XANAX | ALPRAZOLAM | 1 | TAKES IT WHEN SHE GOES FOR SLEEP | 0 | |||||||||||
| 110479569 | 11047956 | 18 | C | CALTRATE | CALCIUM CARBONATE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 19 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 20 | C | VITAMIN B3 | NIACIN | 1 | UNK, WEEKLY | 0 | /wk | ||||||||||
| 110479569 | 11047956 | 21 | C | CARAFATE | SUCRALFATE | 1 | ONE TABLET BEFORE MEAL | 0 | |||||||||||
| 110479569 | 11047956 | 22 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 23 | C | FLUREST | 2 | UNK | 0 | ||||||||||||
| 110479569 | 11047956 | 24 | C | B1 | 2 | UNK, SHE TAKES THAT WITH THE ALPHA LIPOIC | 0 | ||||||||||||
| 110479569 | 11047956 | 25 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 26 | C | BENTYL | DICYCLOMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 110479569 | 11047956 | 27 | C | METAXALONE. | METAXALONE | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 28 | C | CALCIUM CARBONATE W/COLECALCIFEROL | CALCIUM CARBONATECHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 110479569 | 11047956 | 29 | C | ALPHA LIPOIC | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110479569 | 11047956 | 1 | Neuralgia |
| 110479569 | 11047956 | 2 | Pain in extremity |
| 110479569 | 11047956 | 3 | Gait disturbance |
| 110479569 | 11047956 | 4 | Neuropathy peripheral |
| 110479569 | 11047956 | 5 | Pain |
| 110479569 | 11047956 | 21 | Abdominal discomfort |
| 110479569 | 11047956 | 25 | Abdominal discomfort |
| 110479569 | 11047956 | 26 | Muscle spasms |
| 110479569 | 11047956 | 27 | Muscle spasms |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110479569 | 11047956 | OT |
| 110479569 | 11047956 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110479569 | 11047956 | Abdominal pain upper | |
| 110479569 | 11047956 | Constipation | |
| 110479569 | 11047956 | Disease progression | |
| 110479569 | 11047956 | Drug ineffective | |
| 110479569 | 11047956 | Gait disturbance | |
| 110479569 | 11047956 | Hypoaesthesia | |
| 110479569 | 11047956 | Insomnia | |
| 110479569 | 11047956 | Jejunal perforation | |
| 110479569 | 11047956 | Malaise | |
| 110479569 | 11047956 | Muscle spasms | |
| 110479569 | 11047956 | Pain | |
| 110479569 | 11047956 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110479569 | 11047956 | 2 | 20150522 | 0 | ||
| 110479569 | 11047956 | 3 | 20151129 | 0 |